Harnessing Microbial Cells Through Advanced Technologies and Conventional Strategies
Feng‐Wu Bai,Hal S. Alper
DOI: https://doi.org/10.1002/biot.201700558
2017-01-01
Biotechnology Journal
Abstract:Biocatalysts, either microbial cells or enzymes, render biotechnology breakthroughs in fundamentals and applications. Although rational designs with advanced tools and methodologies such as metabolic engineering and synthetic biology are becoming more powerful, conventional strategies including directed/adaptive evolution and process optimization are still indispensable. This special issue contains review and research articles mainly selected from lectures presented at the International Conference on Metabolic Science (ICMS 2016) held on October 20–23, 2016, in Shanghai, China, which was reported in a forum article titled “Metabolic science: Driving bioindustry and beyond”.1 Low overall rates and product titers have been a major challenge for biomanufacture since its emergence, particularly with the production of bulk commodities from renewable resources for sustainable socioeconomic development and ultimately wellbeing of human being. While low rates compromise bioreactors’ productivities, and consequently increase capital investment in production facilities, low product titers make downstream product recovery energy-intensive and discharge more waste. The rationales behind these problems are reviewed and strategies for solutions are proposed by Zhou et al. in their review.2 On the other hand, when yields for biological production by microbes approach theoretical maximum, further improvements present a new challenge, and engineering microbial metabolite dynamics and heterogeneity are thus important, which is critically reviewed by Zhang and colleagues.3 Another host system of interest is microalgae, acknowledged as the 3rd generation feedstock to produce biofuels and bio-based chemicals, but unfortunately high cost with their production is a bottleneck for process development. Screening microalgal strains and their genetic modifications are prerequisites for more efficient biosynthesis and accumulation of carbohydrates and lipids for the biorefinery, which are reviewed by Chang et al.4 Updated progress in strain development and process optimization is highlighted in this issue. To further increase muconic acid production by Saccharomyces cerevisiae engineered with the heterologous pathway, an adaptive evolution strategy using a biosensor module responsive to the endogenous aromatic amino acid as a surrogate for dynamic pathway flux monitoring was developed at Prof. Hal Alper's laboratory.5 Isolated strains with improved biosynthesis were identified for further metabolic engineering, and a similar strategy was also adopted in the production of D-lactic acid by S. cerevisiae at Prof. Ji-Sook Hahn's laboratory.6 Cellulosomes are multi-enzymes self-assembled for hydrolyzing cellulose more efficiently through their synergy, which may overcome intrinsic drawbacks of cellulases, but the understanding of fundamentals underlying this workhorse is incomplete. Taking cellulosomes in the bacterium Thermobifida fusca as examples, the impact of the modular structure of Cel6B, a key exoglucanase of the multi-enzyme system, on its enzymatic activity was investigated by Prof. Edward A. Bayer and his co-workers, and the progress provides insights for designing artificial cellulosomes which are better than natural ones.7 Engineered S. cerevisiae with cellulases for ethanol production from lignocellulosic biomass through consolidated bioprocessing is another frontier. In this regard, cellulolytic activities were significantly improved when cellobiohydrolase secretion was enhanced by expressing the heterologous gene on a high copy episomal vector, which was reported by den Haan et al.8 As dietary supplement and potential drug, N-acetylglucosamine is produced mainly through acid hydrolysis of chitins with environmental hazards. The microbial production of these products was further improved in a recombinant Bacillus subtilis strain previously developed by Liu and his co-workers through engineering both the glucose transportation and central metabolic pathways.9 The potency of metabolic engineering is exhibited in the work performed by Yu et al. on the production of hyaluronic acid through the manipulations of multiple genes encoding key enzymes of the pathway.10 2-Phenylethanol is an important product used in the fragrance and food industries, and its heterologous production by Escherichia coli was developed by Prof. David R. Nielsen and his coworkers to replace extraction from plant biomass or chemical synthesis,11 which once again highlights the contribution of synthetic biology to building up novel pathways in chassis cells. Optimized conditions can explore potentials of biocatalysts. As a biofuel, butanol contains more energy, and has many other advantages over ethanol, but high cost with feedstock consumption in its fermentative production and intensive energy requirement in butanol recovery due to low butanol yield and titer associated with ABE fermentation make it not economically competitive. Jerusalem artichoke (JA) can grow well in marginal lands with high biomass yield, and thus is a potential energy crop for biorefinery. Butanol production from JA tubers by Clostridium acetobutylicum was investigated by Bai et al., but fructose utilization was very poor, and an ORP control strategy based on microaeration was thus developed for the anaerobic fermentation process, which significantly improved fructose utilization and butanol production.12 Fundamentals are always driving technological innovations. Blenner and his coworkers identified a short (200 bp) upstream regulatory sequence in the peroxisomal acyl CoA oxidase 2 (POX2) promoter in the oleaginous yeast Yarrowia lipolytica for engineering to more efficiently induce the expression of genes related to glucose metabolism and the biosynthesis of lipids, providing a useful tool for developing robust strains.13 Prof. Mattheos Koffas and his coworkers engineered E. coli to produce recombinant chondroitinase ACII and characterized its enzymology properties with an expectation of providing critical enzyme for the glycobiology research.14 As the guest editors, we express our sincere thanks to all authors and reviewers for their dedicated contributions and valuable comments. We are also very grateful to the support and various help from the editorial team of Biotechnology Journal, specifically to the Editor-in-Chief Prof. Sang-Yup Lee and the Deputy Editor Dr. Jing Zhu. We hope you enjoy this special issue dedicated to advances in the metabolic sciences and their applications. Prof. Feng-Wu Bai* Shanghai Jiao Tong University, Shanghai, China E-mail: fwbai@sjtu.edu.cn Prof. Hal Alper The University of Texas at Austin, USA E-mail: halper@che.utexas.edu